Detalles de la búsqueda
1.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
Lancet
; 401(10378): 733-746, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764316
2.
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Cancer Immunol Immunother
; 71(2): 327-337, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34164709
3.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658845
4.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Acta Oncol
; 59(9): 1058-1063, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762415
5.
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.
Support Care Cancer
; 28(1): 177-184, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31001696
6.
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents.
Oral Dis
; 26(5): 955-966, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011077
7.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
BMC Cancer
; 13: 163, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537287
8.
Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study.
Curr Oncol
; 30(8): 7608-7619, 2023 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37623032
9.
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Anticancer Res
; 43(6): 2799-2812, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247889
10.
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Anticancer Res
; 43(5): 2243-2258, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097667
11.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725084
12.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
JTO Clin Res Rep
; 4(1): 100433, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793384
13.
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
J Thorac Oncol
; 18(1): 79-92, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049658
14.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
J Thorac Oncol
; 18(8): 1055-1069, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146754
15.
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Clin Lung Cancer
; 24(4): 381-387, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959048
16.
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Breast Cancer Res
; 14(6): R145, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23146280
17.
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.
Cureus
; 14(7): e27266, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039252
18.
Lung Cancer Screening in Greece: A Modelling Study to Estimate the Impact on Lung Cancer Life Years.
Cancers (Basel)
; 14(22)2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428577
19.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Front Oncol
; 12: 934638, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837107
20.
Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.
Cancers (Basel)
; 14(22)2022 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428728